|
Profile
|
Delegates :
Kouichi Kuromi |
|
Incorporated :
December 27 , 2005 |
Paid in Capital :
92 Million yen |
Employees :
5 人 |
Address :
LVP 1-511 Ono-cho 75-1, Tsurumi-ku, Yokohama-shi KANAGAWA
〒230-0046
|
TEL/FAX :
+81-45-501-1714 / +81-45-501-1715 |
URL:
www.libmec.com |
Attachment :
|
Mission/Background :
BioMedCore was founded in the end of 2005 as a spined venture from Tokai univ. with IP on MCL(Mannose Coated Liposome)enable to perform as a very strong vaccine adjuvant as well as DDS carrier. Our mission is to contribute human's healthcare with our liposome DDS dedicated technologies. We will commit excellent service from initial liposomal forlumating stage to GMP sample drug production. On the other hand, we execute sales and commercial production of liposomal medical nutrition supplement in our own facility. |
Technology & Business
|
We BioMedCore, Inc. perform liposomal drug development, liposome dedicated CDMO, liposomal supplement nutrition business used innovative ‘LibMec method’ GMP eligible liposome production technology. Libmec is patented enabling to manufacture sterilized and uniform liposome regardless of any particle size, excellent reproducibility, consistently scale up with ease. We move forward R&D of liposome DDS drug pile lines collaborated with some academia, like as retinal disease therapeutic eye drop, cancer liposomal vaccine. On the other hand, development of unique liposomal medical supplement featured bioavailability immune activity improvement and supply them to the medical oriented commercial market is another pillar of our business.
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Liposomal drug oriented CDMO
|
Service/Marketing
|
From initial formulation to GMP drug production service
|
New opportunity attainment
|
Liposomal nutrition products as medical supplement
|
Launched
|
Large scale production in our own facility, proceed new products development.
|
Commercial launch of new product in this year
|
|
|
|
|
|
|
|
|
|
|
|
|
Alliance strategy
|
Looking for a now alliance of Co-R&D in several liposomal DDS drug programs. Furthermore, joint business of functional liposomal nutrition consolidated with partner's attractive food additives and our liposomal production technology.
|
|
|